- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01563887
Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)
Identifying Driving Risk Factors in T1DM and Their Reduction Via Behavioral Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators have demonstrated that drivers with Type 1 diabetes have at least twice as many collisions as their non-diabetic spouses, that about half of drivers with Type 1 diabetes have at least one hypoglycemic driving mishap a year, and 5% have at least six such events in a year. However, at this point the investigators can not accurately predict those individuals who will have hypoglycemia driving mishaps, which is one goal of this study. The investigators have also demonstrated that face-to-face behavioral interventions focusing on reducing the occurrence of hypoglycemia have lead to significantly fewer vehicular collisions and citations. The question arises whether such a behavioral intervention, specifically focused on reducing hypoglycemia while driving, can be effectively delivered over the internet.
Participants will first complete an Interest form. This questionnaire is used to determine an individual's presumed risk category (high or low risk). Research staff will use the risk category to randomly assign participants to one of four groups according to the randomization scheme. The four groups include: 1) Routine Care - low risk, 2) Routine Care - high risk, 3) DiabetesDriving.com (DD.com) where they will participate in an Internet intervention, 4) DiabetesDriving.com + Motivational Interviewing (MI) where subjects will receive the Internet intervention and two 60 minute MI sessions over the telephone. The MI sessions will take place once before and once following completion of the Internet intervention (within 7 days). This interview will focus on making explicit individuals' ambivalence around changing behavior.
Individuals assigned to the DD.com and DD.com+MI groups will complete 6 Cores, or classes over the internet, focusing on risk factors and prevention, detection, and management of hypoglycemia before and while driving. Each core will take approximately 30 minutes to complete. Core 0 is a tutorial on how to use the internet program. Core 1 focuses on how to use the Tool Kit; Core 2 focuses on how to be a safer driver in general; Core 3 focuses on how to prevent hypoglycemia from occurring while driving; Core 4 focuses on detecting and treating hypoglycemia during a drive; Core 5 focuses on how to maintain the improvements they have achieved in the previous Core over the next 12 months.
After completing a Core, individuals must wait a week before they can start the next Core. During this time individuals will complete at least three Daily Progress Notes, where they will rate their success at achieving their driving goals established in the previous Core. The Cores will take up to 8 weeks to complete before completing Driving Survey 2.
All participants will complete Driving Surveys and monthly driving diaries. The first Driving Survey (Driving Survey 0) will be available to participants as soon as they are consented. Driving Surveys will then be given at 2 and 14 months after submission of Driving Survey 0. Participants will also complete monthly driving diaries, where they will report their driving experiences for the full previous month. Monthly driving diaries will be available on the first day of the next full month 98 days (14 weeks) after completing the Driving Survey at month 2 and continue for 12 months. Twenty-six months after submitting Driving Survey 0, participants will be emailed for a two year follow-up. They will be asked to complete a brief questionnaire on driving outcomes (collisions, citations, etc.).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have been diagnosed with Type 1 diabetes for at least one year
- Started taking insulin less than a year after being diagnosed with Type 1 diabetes
- Measure blood glucose at least twice a day
- Legal and valid driver's license
- Drives greater than 5,000 per year
- Regular access to the Internet, either through family computer or another readily accessible computer
- Age 18 - 70 years
- English speaker
Exclusion Criteria:
- Type 2 diabetes
- Does not take insulin
- Does not drive
- Does not have legal and valid driver's license
- Does not have routine access to the internet
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DD.com
Participants in this arm will receive the DiabetesDriving.com
internet intervention intended to help reduce their risk of being in a future collision.
|
Internet intervention in which participants will complete 6 Cores, or classes over the internet, focusing on risk factors and prevention, detection, and management of hypoglycemia before and while driving.
|
|
Experimental: DD.com + MI
Participants will receive the DiabetesDriving Internet intervention and two 60 minute Motivational Interview (MI) sessions over the telephone.
The MI sessions will take place once before and once following completion of the Internet intervention.
This interview will focus on making explicit individual's ambivalence around changing behavior.
|
Prior to starting and immediately after finishing the DiabetesDriving.com
internet intervention, a one hour motivational interview will be conducted with participants.
Internet intervention in which participants will complete 6 Cores, or classes over the internet, focusing on risk factors and prevention, detection, and management of hypoglycemia before and while driving.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change in the number of hypoglycemia-related driving mishaps
Time Frame: 10 weeks and 62 weeks after submitting the first Driving Survey
|
Driving Surveys will be completed prior to study initiation, immediately after the intervention is finished, and again in one year.
Monthly Driving Diaries will be completed each month for the year after the intervention finishes beginning 14 weeks after submitting the first Driving Survey.
|
10 weeks and 62 weeks after submitting the first Driving Survey
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel J Cox, Ph.D., University of Virginia
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15360
- 5R01DK028288-25 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoglycemia
-
Amylyx Pharmaceuticals Inc.AvailablePost-bariatric HypoglycemiaUnited States
-
Baylor Research InstituteRecruiting
-
Odense University HospitalZealand University HospitalRecruitingHyperglycemia | Diabetes Mellitus | Hypoglycemia (Diabetic) | Hypoglycemia NightDenmark
-
MBX BiosciencesRecruitingPostbariatric HypoglycemiaUnited States
-
MBX BiosciencesProSciento, Inc.CompletedPostbariatric HypoglycemiaUnited States
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimTerminatedPostprandial HypoglycemiaSwitzerland
-
Vogenx, Inc.CompletedPostbariatric HypoglycemiaUnited States
-
University of NebraskaCompletedNeonatal HypoglycemiaUnited States
-
Stanford UniversityCompletedNeonatal HypoglycemiaUnited States
-
Diva De LeonLester and Liesel Baker FoundationCompletedPostprandial HypoglycemiaUnited States